Oakstone Intensive Review of Nephrology 2025

New Release! Unmatched Board Prep and Nephrology Update

The Intensive Review of Nephrology is an advanced online video course from School, designed to deliver an in-depth update across all areas of nephrology. Through 70+ expert-led lectures and case discussions, you’ll gain essential, evidence-based knowledge for optimizing diagnosis, treatment, and patient outcomes.

This continuing medical education program is ideal for clinicians seeking a comprehensive review and physicians preparing for ABIM certification or recertification. Expert faculty evidence-driven strategies for managing common and complex renal conditions. Highlights include:

• Genetic testing for improved diagnosis, prognosis and therapy selection
• Introduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation
• Physical exam of the dialysis access
• Further expansion of the roles of SGLT2i and finerenone in diabetic and non-diabetic kidney disease
• New insights in immunology and the pathogenesis of glomerulonephritis
• Novel immunosuppressive agents for glomerulonephritis
• And more…

Date of Original Release: October 15, 2025
Estimated Time to Complete the Activity: 50.00 hours

Learning Objectives

Upon completion of this activity, participants will be able to:

• Summarize current/recommended nephrology guidelines in clinical practice
• Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
• Identify/integrate current therapeutic options for specific renal disorders
• Review and interpret up-to-date literature relevant to clinical practice
• Describe pathophysiological mechanisms as they apply to management of renal disease
• Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

Target Audience

The target audience for the” Intensive Review of Nephrology” Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Topics:

• Renal Physiology for the Boards – Melanie P. Hoenig, MD
• Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD
• Question and Answer Session – Faculty
• Renal Pathology in 2025 – Part 1 – Nephritic Conditions – Helmut G. Rennke, MD
• Renal Pathology in 2025 – Part 2 – Nephritic Syndrome – Astrid Weins, MD, PhD
• Urine Sediment Analysis – Martina M. McGrath, MB BCh
• Question and Answer Session – Faculty
• Pathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD
• Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
• Keynote – AI in Nephrology – Girish N. Nadkarni, MD, MPH, CPH
• Question and Answer Session – Faculty
• Treating Lupus Nephritis in 2025 – New Guidelines, New Medications, and New Challenges – Gerald B. Appel, MD
• Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
• Anemia Management – Update and Best Practices – Brona M. Moloney, MBBCH, BAO, MMSc
• Question and Answer Session – Faculty
• Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir
• Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, Bchir
• Question and Answer Session – Faculty
• Sodium Disorders – David B. Mount, MD
• Potassium Disorders – David B. Mount, MD
• Question and Answer Session – Faculty
• Important New Trials in GN – David B. Mount, MD
• Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
• Update on Polycystic Kidney Disease – Fouad T. Chebib, MD, FASN
• Pediatric Nephrology – Michael J.G. Somers, MD
• Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD
• Diagnosis and Treatment of ANCA-associated Vasculitis – John L. Niles, MD
• Question and Answer Session – Faculty
• Why Do We Reject a Transplant? – Jamil R. Azzi, MD
• Transplant Immunosuppression for the Boards – Brittany L. Schreiber, MD
• Question and Answer Session – Faculty
• Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
• Early Post-Transplant Management – Anil K. Chandraker, MD
• Question and Answer Session – Faculty
• Evaluation of the Living Donor Candidate – Kassem Safa, MD
• Late Loss of the Kidney Transplant – Rania Khedher El Fekih, MD
• Infections in Transplant Recipients – Barbra M. Blair, MD
• Monitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD
• Pre-Transplant Surgical Evaluation of Recipients – Rania Khedher El Fekih, MD
• Question and Answer Session – Faculty
• Poisonings and Intoxications – What a Nephrologist Needs to Know – Charlotte E. Goldfine, MD
• Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
• Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD
• Geriatric Nephrology – Ernest I. Mandel, MD
• Cardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
• Management of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD
• Question and Answer Session – Faculty
• Primary Aldosteronism – Anand Vaidya, MD, MMSc
• Keynote – Climate Change, Global Inequities, and the Kidney – Valerie A. Luyckx, MBBCh, MSc, PhD
• Liver and the Kidney – Andrew S. Allegretti, MD, MSc
• Question and Answer Session – Faculty
• Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
• Acute Kidney Injury Syndromes – Alice Sheridan, MD
• ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
• Question and Answer Session – Faculty
• Acute Kidney Injury in Cancer – Raad Chowdhury, MD
• Paraprotein-Induced Kidney Injury – Raad Chowdhury, MD
• Therapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2025 – Richard J. Glassock, MD
• Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh
• APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD
• Question and Answer Session – Faculty
• Patient Perspective – Dialysis Dosing – Moderators – J. Kevin Tucker, MD and Paul Moore; Dialysis Patients – Daphne Rhodes and Vanessa Evans
• Chronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD
• Question and Answer Session – Faculty
• Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
• Chronic Kidney Disease – Mineral and Bone Disease Case-Based Pearls – David Bushinsky, MD
• Chronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh
• Question and Answer Session – Faculty
• Introduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
• Complications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
• Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD
• Question and Answer Session – Faculty
• Mesoamerican Nephropathy – David J. Friedman, MD
• Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
• Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD
• Question and Answer Session – Faculty
• Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD
• Must-Know Clinical Images in Nephrology – Annie Liu, DO, MPH, MS
• Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, Bchir
• Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, Bchir
• Chronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP
• COVID-19 Vaccination in Immunocompromised Patients – Ann Woolley, MD
• Update on Renovascular Disease – Joseph M. Garasic, MD
• Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD
• Immunologic Basis of Kidney Disease – Vivek Kasinath, MD
• Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD
• Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH
• Ethics in Nephrology – Valerie Luyckx, MD, MB BCh
• Pregnancy and Renal Disease – Jessica Tangren, MD
• Transplant Cases – Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, MD
• Transplant Board Review – Anil K. Chandraker, MD
• Must-Know Board Zebras – Emily Robinson, MD, MPH
• Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI
• Nephrology Board Review Practice 2 – Gearoid M. McMahon, MB BCh